Myocarditis in a congenital STAT1 gain-of-function patient

被引：0

作者：

Roosens, Willem ^{[1
]}

Staels, Frederik ^{[2
]}

Herrero, Cecilia Iglesias ^{[1
]}

Gijsbergs, Rik ^{[3
]}

Moens, Leen ^{[1
]}

Bossuyt, Xavier ^{[4
]}

Bogaert, Jan ^{[5
]}

Meyts, Isabelle ^{[4
]}

Van Aelst, Lucas ^{[4
]}

Schrijvers, Rik ^{[4
]}

机构：

[1] Katholieke Univ Leuven, Leuven, Belgium

[2] UZ Leuven, Pneumol, Leuven, Belgium

[3] Katholieke Univ Leuven, Mol Med, Leuven, Belgium

[4] Katholieke Univ Leuven, UZ Leuven, Leuven, Belgium

[5] Katholieke Univ Leuven, UZ Leuven, Cardiovasc Imaging, Leuven, Belgium

来源：

CLINICAL IMMUNOLOGY | 2023年 / 250卷

关键词：

STAT1; GOF; Myocarditis; Infectious susceptibility; Chronic mucocutaneous candidiasis;

D O I：

10.1016/j.clim.2023.109417

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：31 / 32

页数：2

共 50 条

[21] Novel STAT1 gain-of-function variant in a patient with Bechet's like clinical phenotype
Aluri, Jahnavi
Schmitt, Erica
Kolicheski, Ana
Du, Matthew
Saucier, Nermina
Cooper, Megan
CLINICAL IMMUNOLOGY, 2023, 250 : 1 - 2
[22] STAT1 GAIN-OF-FUNCTION MUTATION IN A PATIENT WITH MULTIFOCAL ENTEROCOLITIS, SLE, AND FAMILY HISTORY OF CMC
Nawaz, S.
Lee, G.
Tison, K.
Kobrynski, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S91 - S91
[23] Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation
Olivier, N.
Boralevi, F.
Fricain, J. -C.
Doutre, M. -S.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : E899 - E902
[24] STAT1 Gain-of-Function Leading to Clinical Behcet's Syndrome
Aluri, Jahnavi
Schmitt, Erica
Du, Matthew A.
Cooper, Megan
JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1155 - 1158
[25] Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency
Stella P. Hartono
Alexander Vargas-Hernández
Mark J. Ponsford
Ivan K. Chinn
Stephen Jolles
Keith Wilson
Lisa R. Forbes
Journal of Clinical Immunology, 2018, 38 : 753 - 756
[26] Case Report: Eosinophilic Esophagitis in a Patient With a Novel STAT1 Gain-of-Function Pathogenic Variant
Scott, Ori
Sharfe, Nigel
Dadi, Harjit
Vong, Linda
Garkaby, Jenny
Abrego Fuentes, Laura
Willett Pachul, Jessica
Nelles, Sandra
Nahum, Amit
Roifman, Chaim M.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[27] Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)
Meesilpavikkai, Kornvalee
Dik, Willem A.
Schrijver, Benjamin
Nagtzaam, Nicole M. A.
Posthumus-van Sluijs, Sandra J.
van Hagen, P. Martin
Dalm, Virgil A. S. H.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (01) : 328 - 330
[28] Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency
Hartono, Stella P.
Vargas-Hernandez, Alexander
Ponsford, Mark J.
Chinn, Ivan K.
Jolles, Stephen
Wilson, Keith
Forbes, Lisa R.
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (07) : 753 - 756
[29] Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis
Bloomfield, Marketa
Zentsova, Irena
Milota, Tomas
Sediva, Anna
Parackova, Zuzana
FRONTIERS IN IMMUNOLOGY, 2022, 13
[30] STAT1 Gain-of-Function and Hidradenitis Suppurativa Successfully Managed with Baricitinib
Olbrich, Peter
Cortes, Jose Ivorra
Neth, Olaf
Blanco-Lobo, Pilar
JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (05) : 898 - 901

← 1 2 3 4 5 →